Neurocrine Biosciences (NBIX) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $157.79 --0%
EPS Growth %: -12.4%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
VIVO, PMCB, PLCE, More
EPS Growth %: -12.4%
Financial Fact:
Income (loss) from operations: -38.44M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q2 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ciena beats estimates on strong AI-driven demand, shares rise
- Lands' End (LE) Tops Q2 EPS by 1c
- Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
